Pages that link to "Q44074186"
Jump to navigation
Jump to search
The following pages link to The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. (Q44074186):
Displaying 50 items.
- Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease (Q26770224) (← links)
- Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street (Q26799357) (← links)
- CAR T Cell Therapy: A Game Changer in Cancer Treatment (Q26822769) (← links)
- Significance of T helper 17 immunity in transplantation (Q26998887) (← links)
- Novel immunotherapies for hematologic malignancies (Q27004436) (← links)
- Chimeric antigen receptor therapy for cancer (Q27013599) (← links)
- Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic (Q28075992) (← links)
- β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. (Q33578997) (← links)
- Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. (Q33784707) (← links)
- An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition (Q33798102) (← links)
- Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade (Q33809102) (← links)
- Protective effector memory CD4 T cells depend on ICOS for survival (Q33833601) (← links)
- Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells (Q33910157) (← links)
- High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept (Q34014967) (← links)
- ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells (Q34047847) (← links)
- Immune evasion strategies used by Helicobacter pylori (Q34255412) (← links)
- The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors (Q34309388) (← links)
- Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies (Q34517192) (← links)
- Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling (Q34534351) (← links)
- Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression (Q34613311) (← links)
- Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS (Q35220408) (← links)
- IL-17 Enhances Chemotaxis of Primary Human B Cells during Asthma (Q35507974) (← links)
- Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L (Q35527988) (← links)
- Interleukin-22: immunobiology and pathology (Q35530956) (← links)
- Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling (Q35674805) (← links)
- Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation (Q35884238) (← links)
- Human TH17 cells are long-lived effector memory cells. (Q35937849) (← links)
- A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth (Q36038477) (← links)
- Type17 T-cells in central nervous system autoimmunity and tumors. (Q36075677) (← links)
- Regulation of TH17 cell differentiation by innate immune signals (Q36178278) (← links)
- Astute Clinician Report: A Novel 10 bp Frameshift Deletion in Exon 2 of ICOS Causes a Combined Immunodeficiency Associated with an Enteritis and Hepatitis (Q36234338) (← links)
- Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation (Q36562605) (← links)
- Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor (Q36659270) (← links)
- Essentials of Th17 cell commitment and plasticity (Q36730400) (← links)
- Biomimetic delivery with micro- and nanoparticles (Q36768786) (← links)
- Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells (Q36777093) (← links)
- Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus (Q36811763) (← links)
- B7h (ICOS-L) maintains tolerance at the fetomaternal interface (Q36888297) (← links)
- Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease (Q36904560) (← links)
- Chimeric antigen receptor-modified T cells strike back (Q37040370) (← links)
- Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. (Q37105137) (← links)
- Adipocytes as immune regulatory cells (Q37118976) (← links)
- Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus (Q37190065) (← links)
- "Model t" cells: a time-tested vehicle for gene therapy (Q37201423) (← links)
- CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection (Q37241378) (← links)
- Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology (Q37257207) (← links)
- Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies (Q37296295) (← links)
- Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis (Q37526168) (← links)
- Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen (Q37559617) (← links)
- Exploiting the curative potential of adoptive T-cell therapy for cancer (Q37576033) (← links)